Chinese Pharmaceuticals have been sold off considerably in recent months, but look very attractive on a valuation basis. There are fundamental problems, but in light of China’s objective of universal health care coverage there is significant upside. See “Healthy Tigers” update in “Inside The Stock Market”.
Aug
04
2011
Asia Thematic Investing: Update On Healthy Tigers Index
Login
For full access, please enter your credentials.
Not a Subscriber?
If you are interested in subscribing to The Leuthold Group, contact us online or give us a call at 612-332-1567.
Contact UsAbout The Author
Perception for the Professional
March 2026 Issue
Featured Articles
Sector Navigator
March 2026 Issue
Recent Tags
Momentum
(185)
Small Caps
(190)
Factors
(93)
Inflation
(585)
GDP
(45)
Trump
(2)
Time Cycles
(7)
China
(46)
Germany
(5)
Banks
(18)
Dreams and Nightmares
(6)
Debt
(14)
Bank Lending
(2)
Recession
(71)
Capex
(20)
4% Club
(8)
Stablecoins
(1)
Dollar
(55)
Tobacco
(9)
Recession Dashboard
(4)